Article
Teratogen update: Angiotensin‐converting enzyme inhibitors
1 Dec 1994
Abstract excerpt
Occasionally there is a drug whose record in pregnancy is so frequently associated with adverse outcome of so specific a pattern that it becomes clear that its use must be restricted before scientific proof from epidemiological studies is obtained. I believe this to be the case with the drug class of ACEIs. There are mammalian models suggesting substantial fetotoxicity in a dose-related fashion. There is a strong...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
